NSAID-related gastrointestinal complications

Clinical Cornerstone

Volumn 1, Issue 5, 1999, Pages 42-56

  Soll, Andrew H ^a,b   McCarthy, Denis ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Gtr Los Angeles VA Hlthcare System   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d USAF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATHOLOGY; PEPTIC ULCER; REVIEW; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PROSTAGLANDINS; RISK FACTORS;

EID: 0033249829     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(99)90088-1     Document Type: Article

References (21)

1. Lanas AI, Arroyo MT, Esteva F, et al. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut. 1996;39:654-660.
2. Geraghty RJ, Black D, Bruce SA. The successful medical management of gastric outflow obstruction associated with the use of non-steroidal anti-inflammatory drugs in the elderly. Postgrad Med J. 1991;67:1004-1007.
3. Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol. 1990;12:260-266.
4. Kurata JH. An assessment of nonsteroidal antiinflammatory drugs as a risk factor in ulcer disease. Ann Intern Med. 1991;114:311-315.
5. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med. 1996;104:390-398.
6. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787-796.
7. Griffin MR, Smalley WE. Drugs and ulcers: clues about mucosal protection from epidemiologic studies. J Clin Gastroenterol. 1995;21(suppl 1):S113-S119.
8. Carson JL, Strom BL, Soper KA, et al. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987;147:85-88.
9. MacDonald WC. Correlation of mucosal histology and aspirin intake in chronic gastric ulcer. Gastroenterology. 1973;65:381-389.
10. Laine L, Marin-Sorensen M, Weinstein WM. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol. 1992;87: 1398-1402.
11. Ekstrom P, Carling L, Wetterhus S, Wingren PE, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol. 1996;31:753-758.
12. Graham DY, Lidsky MD, Cox AM, et al. Longterm nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991;100:1653-1657.
13. Hawkey GM, Stack WA, Pearson G, et al. Nonsteroidal anti-inflammatory drugs, aspirin and Helicobacter pylori as risk factors for bleeding peptic ulcer [abstract]. Gut. 1997;41(suppl 3):A5.
14. Henry D, Lim LL, Garcia RL, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis [see comments]. BMJ. 1996;312:1563-1566.
15. Chan FK, Sung JJ, Chung SC, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997;350:975-979.
16. . NIH Consensus Development Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease [review; see comments]. JAMA. 1994;272:65-69.
17. Chan FK, Sung JY, Suen R, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomized study. Gastroenterology. 1998;114:A87. Abstract.
18. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1995;123:241-249.
19. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. NEJM. 1998;338:727-734.
20. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-Associated Ulcer Treatment (ASTRONAUT) Study Group. NEJM. 1998;338: 719-726.
21. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of non-steroidal antiinflammatory drug associated gastric and duodenal ulcers. Gut. 1991;32:252-255.